HYFT
ImmunoPrecise Antibodies Ltd.
NASDAQ: HYFT · HEALTHCARE · BIOTECHNOLOGY
$1.19
+0.00% today
Updated 2026-04-30
Market cap
$54.19M
P/E ratio
—
P/S ratio
1.93x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $3
Volume
0.3M
ImmunoPrecise Antibodies Ltd. (HYFT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
+28.6%
Last 4 quarters
Revenue YoY growth
-35.9%
Most recent quarter
EPS YoY growth
+91.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.1%
2025-12-15
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $-0.06 | -63.3% | $1.28 | $1.24 | -3.1% |
| 2025-12-15 | $-0.07 | -366.7% | $1.77 | $1.68 | -5.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-01-31 | $-0.04 | $-0.06 | -63.3% | $4.09M | -35.9% |
| 2025-10-31 | $-0.02 | $-0.07 | -366.7% | $4.17M | +52.5% |
| 2025-07-31 | $-0.04 | $-0.09 | -109.3% | $3.17M | +26.4% |
| 2025-04-30 | $-0.07 | $-0.05 | +28.6% | $6.79M | +4.4% |
| 2025-01-31 | $-0.08 | $-0.66 | -725.0% | $6.38M | +3.2% |
| 2024-10-31 | $-0.07 | $-0.06 | +8.3% | $2.73M | -56.1% |
| 2024-07-31 | — | $-0.11 | — | $2.51M | -55.5% |
| 2024-04-30 | — | $-0.49 | — | $6.50M | +15.0% |
| 2024-01-31 | — | $-0.08 | — | $6.18M | — |
| 2023-10-31 | — | $-0.08 | — | $6.23M | — |
| 2023-07-31 | — | $-0.11 | — | $5.63M | — |
| 2023-04-30 | — | $-0.15 | — | $5.65M | — |
Frequently asked questions
Has ImmunoPrecise Antibodies Ltd. beaten earnings estimates?
ImmunoPrecise Antibodies Ltd. has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of +28.6% over the last 1 quarters.
How does HYFT stock react to earnings?
HYFT stock has moved an average of -4.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is ImmunoPrecise Antibodies Ltd.'s revenue growth rate?
ImmunoPrecise Antibodies Ltd. reported year-over-year revenue growth of -35.9% in its most recent quarter, with EPS growing +91.1% year-over-year.